Volume 41, Issue 3, Pages (September 2014)

Slides:



Advertisements
Similar presentations
Cheng-Ming Sun, Edith Deriaud, Claude Leclerc, Richard Lo-Man  Immunity 
Advertisements

Volume 22, Issue 4, Pages e4 (October 2017)
Volume 25, Issue 2, Pages (August 2006)
Volume 33, Issue 3, Pages (September 2010)
Volume 40, Issue 1, Pages (January 2014)
Identification of CD3+CD4−CD8− T Cells as Potential Regulatory Cells in an Experimental Murine Model of Graft-Versus-Host Skin Disease (GVHD)  Fumi Miyagawa,
Volume 28, Issue 2, Pages (February 2008)
Wei Hu, Ty Dale Troutman, Ramakrishna Edukulla, Chandrashekhar Pasare 
Volume 34, Issue 3, Pages (March 2011)
Hans-Peter Raué, Carol Beadling, Jennifer Haun, Mark K. Slifka 
Volume 31, Issue 2, Pages (August 2009)
Volume 34, Issue 1, Pages (January 2011)
Volume 32, Issue 3, Pages (March 2010)
Volume 30, Issue 4, Pages (April 2009)
Volume 18, Issue 5, Pages (May 2003)
Volume 45, Issue 6, Pages (December 2016)
Volume 36, Issue 5, Pages (May 2012)
Volume 13, Issue 4, Pages (April 2013)
Volume 140, Issue 7, Pages (June 2011)
Volume 35, Issue 6, Pages (December 2011)
Volume 38, Issue 5, Pages (May 2013)
Volume 35, Issue 1, Pages (July 2011)
Volume 4, Issue 4, Pages (October 2008)
Volume 31, Issue 2, Pages (August 2009)
Maturation, Ag presentation capacity, and IL-12 production of DCs
Volume 18, Issue 3, Pages (March 2003)
Volume 33, Issue 3, Pages (September 2010)
Volume 34, Issue 1, Pages (January 2011)
Volume 32, Issue 2, Pages (February 2010)
Down-Regulation of IL-4 Gene Transcription and Control of Th2 Cell Differentiation by a Mechanism Involving NFAT1  Alexander Kiani, João P.B Viola, Andrew.
Cell-to-Cell Transfer of M
Volume 34, Issue 5, Pages (May 2011)
T Cell-Produced Transforming Growth Factor-β1 Controls T Cell Tolerance and Regulates Th1- and Th17-Cell Differentiation  Ming O. Li, Yisong Y. Wan, Richard.
Volume 24, Issue 6, Pages (June 2006)
Volume 24, Issue 2, Pages (February 2006)
Volume 39, Issue 4, Pages (October 2013)
Volume 29, Issue 6, Pages (December 2008)
Volume 29, Issue 1, Pages (July 2008)
Volume 40, Issue 1, Pages (January 2014)
Volume 36, Issue 6, Pages (June 2012)
Volume 33, Issue 4, Pages (October 2010)
Volume 32, Issue 5, Pages (May 2010)
Volume 38, Issue 3, Pages (March 2013)
Volume 33, Issue 3, Pages (September 2010)
Volume 135, Issue 3, Pages (September 2008)
Volume 38, Issue 3, Pages (March 2013)
Volume 42, Issue 1, Pages (January 2015)
Volume 29, Issue 5, Pages (November 2008)
Volume 9, Issue 5, Pages (May 2011)
Volume 35, Issue 2, Pages (August 2011)
Volume 31, Issue 5, Pages (November 2009)
Volume 36, Issue 5, Pages (May 2012)
Volume 44, Issue 5, Pages (May 2016)
Volume 31, Issue 4, Pages (October 2009)
Karima R.R. Siddiqui, Sophie Laffont, Fiona Powrie  Immunity 
Volume 26, Issue 4, Pages (April 2007)
Volume 34, Issue 3, Pages (March 2011)
Volume 26, Issue 2, Pages (February 2018)
Volume 30, Issue 4, Pages (April 2009)
Volume 28, Issue 5, Pages (May 2008)
Volume 131, Issue 6, Pages (December 2006)
Volume 35, Issue 4, Pages (October 2011)
Volume 38, Issue 2, Pages (February 2013)
Volume 32, Issue 1, Pages (January 2010)
Toll-Dependent Control Mechanisms of CD4 T Cell Activation
Volume 35, Issue 1, Pages (July 2011)
Patrizia Stoitzner, Christoph H
Volume 28, Issue 1, Pages (January 2008)
Hepatic Interleukin-7 Expression Regulates T Cell Responses
Volume 25, Issue 3, Pages (September 2006)
Presentation transcript:

Volume 41, Issue 3, Pages 402-413 (September 2014) Dectin-2 Is a Direct Receptor for Mannose-Capped Lipoarabinomannan of Mycobacteria  Akiko Yonekawa, Shinobu Saijo, Yoshihiko Hoshino, Yasunobu Miyake, Eri Ishikawa, Maho Suzukawa, Hiromasa Inoue, Masato Tanaka, Mitsutoshi Yoneyama, Masatsugu Oh-hora, Koichi Akashi, Sho Yamasaki  Immunity  Volume 41, Issue 3, Pages 402-413 (September 2014) DOI: 10.1016/j.immuni.2014.08.005 Copyright © 2014 Elsevier Inc. Terms and Conditions

Immunity 2014 41, 402-413DOI: (10.1016/j.immuni.2014.08.005) Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 1 LAM Induces EAE through FcRγ Axis (A and B) WT (n = 4) and Fcer1g–/– (n = 4) mice were immunized with MOG35-55 peptide in IFA containing LAM (500 μg), followed by i.p. injection of PT (500 ng) (day 1, 2, and 3). The disease severity of each mouse was scored, and mean clinical score (A) and disease incidence (B) at the indicated times were plotted. (C and D) Lumbar (C) and inguinal (D) lymph nodes were collected at 23 days after immunization. Lymph node cells were stimulated with MOG35-55 peptide for 4 days. Concentrations of IL-17, IFN-γ, and GM-CSF were determined with ELISA. (E and F) BMDCs obtained from WT, Clec4e–/–, Fcer1g–/–, or MyD88–/– mice were stimulated with plate-coated LAM (0.3 μg/well) or LPS (10 ng/ml) for 48 hr. The concentrations of MIP-2 (E) and TNF (F) were measured using ELISA. (A–D) Data are representative of two separate experiments. (E and F) All data are presented as the means ± SD of triplicate and are representative of three separate experiments. See also Figure S1. Immunity 2014 41, 402-413DOI: (10.1016/j.immuni.2014.08.005) Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 2 Dectin-2 Recognizes Pathogenic Mycobacterial Species though LAM (A) NFAT-GFP reporter cells expressing Mincle + FcRγ (Mincle) or Dectin-2 + FcRγ (Dectin-2) were stimulated with heat-killed M. tuberculosis H37Rv or M. bovis BCG. TDM and Candida albicans cell wall mannan were used in plate-coated form as a positive control. (B) Reporter cells were stimulated with plate-coated water extract or C:M extract for 24 hr. (C) Reporter cells expressing FcRγ alone or Dectin-2 + FcRγ were stimulated with the indicated amounts of LAM derived from M. tuberculosis strain Aoyama B in plate-coated form for 24 hr. Induction of NFAT-GFP was analyzed using flow cytometry. All data are presented as the means ± SD of triplicate assays and representative results from three independent experiments with similar results are shown. See also Figure S2. Immunity 2014 41, 402-413DOI: (10.1016/j.immuni.2014.08.005) Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 3 Dectin-2 Selectively Recognizes Mannose-Capped LAM (A) NFAT-GFP reporter cells expressing Mincle + FcRγ or Dectin-2 + FcRγ were stimulated with the indicated strains of heat-killed NTM. (B) Reporter cells expressing Dectin-2 + FcRγ were stimulated with M. bovis BCG pretreated with or without α-mannosidase for 24 hr. (C and D) Reporter cells expressing Dectin-2WT + FcRγ or Dectin-2QPD + FcRγ were stimulated with plate-coated LAM (C) and NTM strains (D) for 24 hr. All data are presented as the means ± SD of triplicate and are representative of three separate experiments. See also Figure S3. Immunity 2014 41, 402-413DOI: (10.1016/j.immuni.2014.08.005) Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 4 LAM Induces Cytokine Production in a Dectin-2-Dependent Manner (A–D) BMDCs obtained from WT or Clec4n–/– mice were stimulated with the indicated amounts of plate-coated LAM or TDM for 48 hr (A and C). BMDCs were infected with 1 to 10 × 109 of M. bovis BCG for 48 hr (B and D). LPS was used as control. The concentrations of MIP-2, TNF, IL-6 (A and B), IL-10, and IL-2 (C and D) were measured using ELISA. (E) BMDCs were stimulated for 48 hr with M. bovis BCG or clinical isolates of heat-killed M. abscessus derived from ten individual patients. The concentrations of MIP-2, IL-10, and IL-2 were measured using ELISA. All data are presented as the means ± SD of triplicate and are representative of three separate experiments. See also Figure S4. Immunity 2014 41, 402-413DOI: (10.1016/j.immuni.2014.08.005) Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 5 LAM Does Not Cause Excessive Inflammation in the Lungs (A and B) Mice were intratracheally administered 100 μg of LAM (WT, n = 13; Fcer1g–/–, n = 5), 10 μg of LPS (WT, n = 9), or 100 μl of sterile saline as a control (WT, n = 7). After 8 hr, BALF was obtained and then TNF concentrations in the BALF were determined using ELISA (A). The number of total cells was determined by hemocytometer (B). All data are presented as the means ± SD. (C) Lungs of control mice (Cont., n = 11), 50 μg of LAM (LAM, n = 11)- or 50 μg of TDM (TDM, n = 7)-injected mice were isolated at day 7 and inflammatory intensity was evaluated by calculation of lung weight index. Each symbol represents an individual mouse. Data are representative of three separate experiments. (D) Histology of the lungs from control, LAM (50 μg)-, or TDM (50 μg)-injected mice were was examined by hematoxylin-eosin staining at day 7. Scale bars represent 0.1 mm. Data are representative of three separate experiments. Immunity 2014 41, 402-413DOI: (10.1016/j.immuni.2014.08.005) Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 6 LAM Induces Acquired Immune Responses through Dectin-2 (A) BMDCs obtained from WT, Clec4n–/–, Clec4e–/–, or Fcer1g–/– mice were left untreated or stimulated with plate-coated LAM or LPS for 48 hr. The surface expressions of CD40 and CD80 were analyzed using flow cytometry. (B) BMDCs were pulsed with OVA323-339 peptides and cocultured with CFSE-labeled CD4+ OT-II T cells for 3 days in the presence or absence of plate-coated LAM. Cytokine concentrations were determined using ELISA. Cell proliferation was analyzed using flow cytometry for dilution of CFSE within the CD4+ population. The data are presented as the means ± SD of triplicate and are representative of three separate experiments. (C and D) WT (n = 10) and Clec4n–/– (n = 10) mice were immunized with MOG35-55 peptide in IFA containing LAM (500 μg) as described in Figure 1A. Mean clinical score (C) and disease incidence (D) at the indicated times were plotted. (E) Lymph nodes were collected at 23 days after immunization for EAE and stimulated with MOG35-55 peptide for 4 days. Cytokine concentrations were determined using ELISA. The data are presented as the means ± SD. See also Figure S5. Immunity 2014 41, 402-413DOI: (10.1016/j.immuni.2014.08.005) Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 7 Immune Responses against Mycobacterial Infection in Clec4n–/– Mice (A) Higher lung weights in Clec4n–/– mice. Lungs were isolated 23 days after infection of MAC. WT (n = 10) and Clec4n–/– (n = 10) mice were used. (B) Histological analysis of the lung from uninfected- or MAC-infected WT or Clec4n–/– mice by HE staining. Scale bars represent 0.1 mm. (C) Cytokine production in splenocytes after restimulation with sensitin or MACAg85 for 4 days. Splenocytes were obtained 23 days after infection of MAC and pooled from ten mice in each group. The data are presented as mean ± SD. See also Figure S6. Immunity 2014 41, 402-413DOI: (10.1016/j.immuni.2014.08.005) Copyright © 2014 Elsevier Inc. Terms and Conditions